API provides critical capacity to Edmonton life sciences company
Pictured: Dr. Rakesh Bhat, API Director of Lab Science (left) and Dr. Shadab Alam (right) working in the Doschak Lab. In the drug development industry,…
Read Moreabout API provides critical capacity to Edmonton life sciences company
API and Amii team up as a world leader in drug development and AI
The following release was issued today by Amii and API: EDMONTON, AB, October 10, 2019 – Applied Pharmaceutical Innovation (API) and Alberta Machine Intelligence Institute…
Read Moreabout API and Amii team up as a world leader in drug development and AI
Board Announcement – Jason Pincock and Greg Klak
We’re pleased to announce the two newest additions to the API board of directors: Jason Pincock and Greg Klak. Both are passionate leaders with extensive…
Read Moreabout Board Announcement – Jason Pincock and Greg Klak
The Institute of Health Economics and API collaborate to support early economic analysis for spinoffs and startups
The API is pleased to announce a new collaboration with the Institute of Health Economics. The Institute of Health Economics (IHE) and Applied Pharmaceutical Innovation…
See the latest coverage about API in the Edmonton Journal
On August 9th, API was featured in the Edmonton Journal, read the article below. View the Article here
Read Moreabout See the latest coverage about API in the Edmonton Journal
API Partners with Hepion Pharmaceuticals to Develop NASH treatment
Hepion Pharmaceuticals logo A press release from one of our recent partners Hepion Pharmaceuticals: Hepion Pharmaceuticals Announces Research Partnership with Applied Pharmaceutical Innovation, Faculty of…
Read Moreabout API Partners with Hepion Pharmaceuticals to Develop NASH treatment
Launching with $25 million in industry partnerships, Applied Pharmaceutical Innovation is on track to transform health innovation in Alberta.
Below is the press release for our official launch FOR IMMEDIATE RELEASE EDMONTON, AB, July 30, 2019 – Applied Pharmaceutical Innovation (API) incorporated as a…
6 Month Update
It’s been nearly six months since API was launched as an accelerator for innovation and economic development and we are pleased to announce some of…
Advisory Committee Members
API has launched its Advisory Committee. With a broad group of expertise from multiple areas of the drug development world our committee includes the following…
A bridge across the “Valley of Death”
The challenge faced by academic innovators In the biotech community, there is a problem so common and so frustratingly difficult for many innovators to overcome…
API Soft Launch
After extensive industry engagement that included over 150 consultation meetings with members of the pharmaceutical industry, government partners, and stakeholders, API is now active. We…
